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abstract
Background:	Periodontal	disease,	commonly	known	as	periodontitis	is	an	infectious	disease	which	has	multifactorial	etiologic	
factors.	It	may	affect	everybody	in	any	ages	with	no	gender	nor	sex	predilection	and	usually	can	be	detected	under	routine	clinical	
examination.	This	disease	is	a	manifestation	of	local	factors,	host	factor	and	environmental	factors,	resulting	in	periodontal	tissue	
damage	which	may	cause	 tooth	mobility	and	 tooth	 loss.	 Interleukin-1	 is	a	pro-inflammatory	protein	which	 functions	primarily	as	
inflammatory	mediator	in	host	innate	immune	responses.	IL-1	is	a	regulator,	affecting	many	biological	activities	including	proliferation,	
development,	homeostasis,	regeneration,	repair	and	inflammation	which	contribute	to	tissue	damage	and	alveolar	bone	resorption.	
Purpose: This	research	was	aimed	to	reveal	the	basic	pathogenesis	of	periodontitis	and	could	determine	the	future	definitive	treatment	
for	patients	with	periodontitis.	Methods: Data	were	obtained	from	40	patients	with	aggressive	periodontitis	and	40	patients	with	
chronic	periodontitis.	Samples	were	collected	from	periodontal	tissue	patients	and	protein	expression	of	IL-1b	was	performed	with	
immunohistochemistry.	results:	Most	female	patient	suffer	aggressive	periodontitis	and	chronic	periodontitis.	The	datas	were	analyzed	
with	t-test.	The	t	values	result	was	-8623,	significance	0.001,	with	a =	5%,	which	indicated	there	was	significant	difference	in	IL-1b	
expression	between	aggressive	and	chronic	periodontitis.	The	box	plot	diagram	showed	marked	difference	in	distribution	of	protein	
expression	of	IL-1b	between	patients	with	aggressive	periodontitis	and	chronic	periodontitis.	With	a	regression	equation,	it	might	be	
concluded	that	the	protein	expression	of	IL-1b	might	affect	the	incidence	of	aggressive	periodontitis	and	chronic	periodontitis.	The	
OR	value	was	calculated	for	0.746	(sign.=	0.001),	which	indicate	each	increment	of	one	unit	protein	expression	of	IL-1b	will	lead	the	
risk	for	Aggressive	periodontitis	0.746	times	higher	or	if	the	protein	expression	of	respondents	increased	one	unit,	the	risk	of	chronic	
IL-1b periodontitis	may	be	1.34	times	higher.	Conclusion: This	study	elucidated	that	the	elevation	proteins	expression	of	IL-1b	in	
patients	with	chronic	periodontitis	demonstrated	this	cytokine	as	an	indicator	of	inflammation.
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abstrak
latar belakang:	Penyakit	periodontal	yang	biasa	dikenal	dengan	periodontitis	adalah	penyakit	infeksi,	yang	disebabkan	oleh	
berbagai	 faktor,	 dapat menyerang	 setiap	 orang	 tanpa	membedakan	usia	 dan	gender	 serta	mudah	ditemukan	pada	pemeriksaan	
klinis	oleh	 seorang	dokter	gigi.	Penyakit	 ini	merupakan	manifestasi	dari	 interaksi	antara	 faktor	 lokal	dengan	 faktor	 lingkungan,	
yang	berakibat	 pada	 kerusakan	 jaringan	periodontal,	 dapat	mengakibatkan	 terjadinya	 kegoyangan	gigi	 hingga	 tanggalnya	gigi.	
Interleukin-1	merupakan	protein	pro-inflamatori	dengan	fungsi	utama	sebagai	mediator	respon	inflamasi	pejamu	pada	sistem	imunitas	
innate.	 Interleukin-1	merupakan	 regulator,	 dimana	memainkan	 peranan	 pada	 sejumlah	 aktivitas	 biologic	 termasuk	 proliferasi,	
pengembangan,	homeostasis,	regenerasi,	repair	dan	keradangan	berperan	pada	kerusakan	jaringan	ikat	serta	resorpsi	tulang	alveolar.	
tujuan: Penelitian	ini	bertujuan	untuk	menentukan	dasar	patogenesa	periodontitis	dan	dapat	digunakan	sebagai	dasar	perawatan	
penderita	periodontitis	pada	masa	mendatang.	Metode:	Data	penelitian	didapat	dari	40	penderita	dengan	periodontitis	agresif	dan	
40	penderita	periodontitis	kronis.	Sampel	berasal	dari	jaringan	yang	mengalami	kelainan	periodontal	dan	uji	ekspresi	protein	IL-1b	
dilakukan	secara	imunohistokimia.	hasil: Penderita	yang	mengalami	kelainan	pada	penelitian	ini	sebagian	besar	adalah	perempuan	
baik	periodontitis	agresif	maupun	periodontitis	kronis.	Uji	statistik	yang	digunakan	adalah	uji-t	diperoleh	nilai	t	sebesar	-8.623	dan	
signifikansi	0.001,	dengan	a =	5%	maka	terdapat	perbedaan	bermakna	ekspresi	protein	IL-1b	antara	penderita	periodontitis	agresif	
dan	penderita	periodontitis	kronis. Diagram	box	plot	memperlihatkan	sebaran	ekspresi	protein	IL-1b	antara	penderita	periodontitis	
agresif	dan	penderita	periodontitis	 kronis	 yang	 tampak	 sangat	 jauh	berbeda.	Ekspresi	protein	 IL-1b	 berpengaruh	pada	kejadian	
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penderita	periodontitis	agresif	dan	penderita	periodontitis	kronis,	dengan	bentuk	persamaan	regresi.	Nilai	estimasi	OR	untuk	variabel	
ekspresi	protein	IL-1b	adalah	0,746	(sign.	=	0,00).	Artinya,	jika	ekspresi	protein	IL-1b	responden	bertambah	satu	satuan,	maka	risiko	
terjadinya	periodontitis	agresif	menjadi	0,746	kali	atau	jika	ekspresi	protein	IL-1b	responden	bertambah	satu	satuan,	maka	risiko	
terjadinya	periodontitis	kronis	menjadi	1,34	kali.	Kesimpulan: Ekspresi	protein	Il-1b	yang	meningkat	pada	penderita	periodontitis	
kronis	menujukkan	bahwa	sitokinini	merupakan	indikator	pada	keadaan	keradangan.	
Kata kunci: Periodontitis	agresif,	periodontitis	kronis,	interleukin-1b
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introduction 
Periodontal disease, commonly known as periodontitis, 
is an infectious disease with multifactorial etiologic 
factors which may cause of periodontal tissue destruction. 
Periodontitis is a multifactorial disease with bacterial 
infection as its main etiologic factor, the incidence and 
severity of illness were determined by the host response to 
infection, but until now, clinical diagnosis often remains 
unclear so that treatment often gives unsatisfactory 
results, which may indicate the necessity of exploration in 
molecular level. 
As a marker of active inflammation, the interleukin-1 
(IL-1) plays important role in immunological processes of 
inflammatory response. Interleukin-1 is a pro-inflammatory 
protein produced by macrophages and endothelial 
cells platelets which functions mainly as a mediator of 
inflammatory responses in host innate immunity system. 
IL-1 is a multifunctional cytokine which influences 
most of the inflammatory cell types, is a cytokine that is 
produced during inflammatory processes and involved 
in connective tissue destruction from the early phase. 
IL-1 may function as a regulator, which plays a role in 
a number of biological activities including proliferation, 
development, homeostasis, regeneration, repair and 
inflammation.1,2 Interleukin 1 exists in two forms, namely 
IL-1a and IL-1b. IL-1b is a potent inflammatory cytokine 
involved in many important cellular functions, such as 
proliferation, activation, and differentiation and is an 
important component of the innate immune response 
moreover it; also induces the chemotactic of leukocytes by 
stimulating the induction of IL-8 and activating neutrophils 
for phagocytosis and degranulation. It is also found that 
IL-1b not only modulates the inflammation in gingival 
epithelial cells but also regulates the production of other 
inflammatory cytokines including IL-8.3
 IL-1b is a potent substance that has catabolic effect on 
bone 10 times higher compared to IL-1b. The biological 
impact of IL-1 depends on the amount of cytokines that 
are released by the body. At low levels, it functions as a 
local inflammatory mediators, while in high level, IL-1 
may enter into the circulation and accelerates the endocrine 
activity.4-6 Interleukin-1 may function as a regulator, which 
plays a role in a number of biological activities including 
proliferation, development, homeostasis, regeneration, 
repair and inflammation.1,2
IL-1b stimulate various cell types to produce connective 
tissue catabolic and mediators of bone resorption such as 
IL-1, IL-6, TNFa, PGE2 and matrix metalloproteinase.7 
IL-1b and tumor necrosis factor (TNF) are cytokine that 
possess the ability to cause bone destruction.8,9
Based on those previous studies above, identification 
of IL-1b may be used as a risk factor for periodontitis. 
This research was aimed to reveal the basic pathogenesis 
of periodontitis and could determine the future definitive 
treatment of patients with periodontitis. 
materials and methods 
This research was an analytical observational study, 
case control study design in patients who experienced 
aggressive and chronic periodontitis. Complete medical 
and dental histories were taken from all subjects. None of 
subjects had a history of systemic disease and had received 
antibiotics or other medication or periodontal treatment 
within the past 4 months. Informed consent was obtained 
from the patients and the protocol was approved by the 
Ethical Committee of Faculty of Dentistry Airlangga 
University. Tissue samples were taken from periodontal 
tissue that was affected by periodontitis. 
The population of this research was patients who 
came to Dental Hospital of Faculty of Dentistry Airlangga 
University for 10 month, and had been diagnosed with 
aggressive periodentitis (AP) or chronic periodontitis (CP).
The patients were diagnosed according to clinical and 
radiographic criteria as AP (n = 40) and CP (n = 40).
The parameters were shown as mean ± standard 
deviation and analyzed by t test. The expression of IL-1b 
was detected by immunohistochemistry method. IL-1b was 
detected with biotin-labeled antibodies and visualized with 
DAB-deminobenzidine. 
212 Dent. J. (Maj. Ked. Gigi), Vol. 43. No. 4 December 2010: 210–214
results
The data that were eligible for analysis consisted of 
40 patients with aggressive periodontitis and 40 patients 
with chronic periodontitis. The following diagram 
showed patient distribution with aggressive periodontitis 
and chronic periodontitis during the study which was 
distinguished by gender (Figure 1).
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figure �. Frequency distribution column, based on gender, 
aggressive and chronic periodontitis (AP and CP).
Patients who had periodontal disease, either aggressive 
periodontitis or chronic periodontitis, in this study 
were mostly women. This situation could be seen from 
22 samples (55%) of patients with aggressive periodontitis 
and 24 samples (60%) of patients with chronic periodontitis 
were women (Table 1). 
table �. Descriptive value of protein expression of IL-1b, 
people with aggressive periodontitis (AP) and chronic 
periodontitis (CP) in Surabaya 
Periodontitis N Mean
Standard 
Deviation
Protein 
Expression IL-1b
AP 40 9.32 6.12
CP 40 20 4.87 
Protein expression of IL-1b patient with aggressive 
periodontitis and patient with chronic periodontitis could 
be seen in table 1. The following were data values based 
on examination of 40 patients with aggressive periodontitis 
and 40 patients with chronic periodontitis. The independent 
samples t-test with variances homogeneous data was 
performed to see the difference in protein expression of 
IL-1b between the patient with aggressive periodontitis 
and chronic periodontitis. The t-test values were obtained 
at -8623 and significance of 0.00. If a value was set on 
5%, there was significant difference in protein expression 
of IL-1b patients with aggressive periodontitis and chronic 
periodontitis patients. 
The average of protein expression in patients with 
aggressive periodontitis was 9.32, while in patients 
with chronic periodontitis was 20. Patient with chronic 
periodontitis had significantly higher IL-1b compared to 
patients with aggressive periodontitis (Figure 2).
figure �. Expression of IL-1b protein (arrow) in periodontal 
tissue by immunohistochemistry staining with 
peroxidase DAB and 400× magnification.
The difference of protein expression may be easily 
explained with the box plot diagrams expression of IL-1b 
(Figure 3). The box plots clearly demonstrated the data 
distribution of protein expression between patients with 
aggressive periodontitis and chronic periodontitis.
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figure ��. Box plots of IL-1b protein expression.
Box plot diagram demonstrated the difference of protein 
expression of IL-1 between patients with aggressive and 
chronic periodontitis. With a regression equation, it might 
be concluded that the protein expression of IL-1b might 
affect the incidence aggressive periodontitis and chronic 
periodontitis.
The OR value for protein expression of IL-1b was 
estimated 0.746 (sign = 0.001). It meant each increment of 
one unit protein expression of IL-1b, the risk for aggressive 
periodontitis was 0.746 times higher or if the protein 
expression of respondents increased one unit, the risk of 
chronic periodontitis may be 1.34 times higher.
 
 CP
Aggressive periodontitis  Chronic perindontitis
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discussion
Epithelial cells are one of the first lines of defense 
against pathogens, and although these cells are not as 
specialized as professional phagocytes in dealing with 
pathogens, they may play a sentinel role. The cells may 
use the extracellular secretion of IL-1b to induce other 
neighboring epithelial cells in autocrine manner to help 
amplify the release of inflammatory, chemokine, and 
antimicrobial molecules.
Based on sample characteristics, it seemed that there 
was no gender predilection, because men and women had 
the same representation. However, this study showed that 
periodontitis was more likely to be found in women, possibly 
because womenvisit dentists more often than men and other 
possibilities were the age of puberty was earlier, hormonal 
changes during menstruation and pregnancy might affect 
the host and might also aggravate the periodontitis. It was 
corresponded with the previous studies from Bret et	al.,10 
and Guzeldemir et	al.,1 which found that most of the study 
sample were woman.
The IL-1 is one of cytokine that was functioned in 
periodontal tissues, this kind of interleukin is more dominant 
as IL-1b whichhas various pro-inflammatory capabilities, 
produced during inflammation and involved from the early 
stage of connective tissue damage and was considered as an 
important role in the pathogenesis of periodontitis. IL-1b 
secretion is induced soon after microbial invasion, there for 
it could be hypothesized that IL-1b might play an important 
role in the induction of other inflammatory cytokines.3 
IL-1b stimulates various cells types to produce connective 
tissue and catabolic mediators of bone resorption such as 
IL-6, TNFa, PGE2 and matrix metalloproteinase. Level of 
cytokines which was secreted in response to the bacteria 
may explain individual response differences in sensitivity 
to and severity of the periodontal disease.7,11 The IL-1b 
expression is associated with the severity of inflammatory 
diseases including periodontitis, which then would quickly 
encode pro-inflammatory proteins by transcription factors 
like nuclear factor-kB (NF-kB).12
This research demonstrated an increase in protein 
expression of IL-1b in chronic periodontitis group compared 
with aggressive periodontitis, which was corresponded with 
the research conducted by Gursoy et	al.,13 who also found 
that levels of IL-1b were high in the periodontitis group 
compared with healthy control samples. Levels of IL-1b on 
periodontal tissues might increase according to the severity 
of illness, which was related to the presence of periodontal 
pathogen.3 It shall be noted that gingival inflammation 
may affect the secretion of IL-1b. Research conducted by 
Toker et	al.,6 found that IL-1b was significantly elevated 
in periodontal tissue and gingival fluid of the inflamed 
side compared to the healthy side. In vivo and in vitro 
studies had shown that in patients with periodontitis and 
other infectious diseases, IL-1b which was produced 
was involved in the inflammatory process and aimed to 
eliminate the periodontal pathogen from host.14
High level of IL-1 will stimulate the secretion of CD4 + 
T-cells which will increase the secretion of specific 
antibodies. IL-1 also will stimulate the production of IL-2 
through the Th1 cell, which in turn will stimulate CD8 + T 
cells, and suppress the activation of polyclonal B-cell and 
the production of antigen-specific antibodies. T-helper type 
1 (Th1), Th2 and monocyte derived cytokines in gingival 
tissue and gingival crevicular fluid (GFC) was involved in 
periodontal inflammation. The IL-1b (cytokine) imbalance 
may affect the periodontal supporting bone and collagen 
tissue destruction in patients with periodontitis. Interleukin 
1b may suppress IL-10 production in periodontal ligament 
cells, which mean that there is interaction between IL-1b 
and IL-10, and the dynamic interaction between pro-
inflammatory and anti-inflammatory cytokines plays an 
important role in the pathogenesis of periodontal defects. 
Cytokines determines the local defense against bacterial 
endotoxins and maintain homeostasis in periodontal 
tissues.15,16 Periodontopathogen bacteria that cause 
periodontitis produce lipopolysaccharide, which was 
potential in stimulating host response and contributing to 
tissue damage. It also stimulated macrophages to release 
IL-1b and TNF. This cytokine had the ability to stimulate 
bone destruction.9,17 While neutrophils and the other cells 
that serve as protection were not working properly and at 
the end would cause bone destruction.18
As a multifunctional pro-inflammatory mediator with 
a crucial role in the regulation of inflammatory reactions, 
the observation that IL-1b can act on large number of cells, 
like fibroblast, chondrocytes, bone cells, neutrophils and 
lymphocyte suggests that periodontal destruction and repair 
in periodontitis may in part be associated with this cytokine.
It may be concluded that IL-1b as a marker of active 
inflammation will contribute in pathological inflammatory 
response and periodontitis, as an active inflammation, 
will elevates the level of protein expression. The results 
of this study may be can be used as a further reference on 
therapeutic modality to actively control the inflammation 
and tissue damage in various diseases.
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